Cyanidin‐3‐O‐glucoside improves non‐alcoholic fatty liver disease by promoting PINK1‐mediated mitophagy in mice

Background and Purpose Identifying safe and effective compounds that target to mitophagy to eliminate impaired mitochondria may be an attractive therapeutic strategy for non‐alcoholic fatty liver disease. Here, we investigated the effects of cyanidin‐3‐ O ‐glucoside (C3G) on non‐alcoholic fatty liver disease (NAFLD) and the underlying mechanism. Experimental Approach Non‐alcoholic fatty liver disease was induced by a high‐fat diet for 16 weeks....